Nissui Pharmaceutical Co., Ltd.
Nissui Pharmaceutical Co., Ltd. (4550.T) Stock Competitors & Peer Comparison
See (4550.T) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - General Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 4550.T | ¥1,714.00 | +0.23% | 0 | 0.00 | ¥105,444,448.00 | N/A |
| 4519.T | ¥9,362.00 | -0.71% | 15.4T | 35.46 | ¥264.01 | +2.91% |
| 4578.T | ¥11,005.00 | -0.14% | 5.8T | 15.85 | ¥694.26 | +1.27% |
| 4568.T | ¥2,818.50 | -2.81% | 5.2T | 18.84 | ¥149.58 | +2.45% |
| 4503.T | ¥2,361.50 | -0.46% | 4.2T | 34.03 | ¥69.39 | +3.22% |
| 4151.T | ¥2,331.00 | +1.22% | 1.2T | 18.20 | ¥128.05 | +2.66% |
| 4528.T | ¥2,363.00 | +1.18% | 1.1T | 21.10 | ¥112.00 | +3.39% |
| 4536.T | ¥1,641.00 | +0.49% | 527.9B | 17.72 | ¥92.59 | +2.32% |
| 4552.T | ¥615.00 | -1.13% | 75B | -32.61 | -¥18.86 | +3.25% |
| 4882.T | ¥258.00 | -6.86% | 3.8B | -4.85 | -¥53.24 | N/A |
Stock Comparison
4550.T vs 4519.T Comparison March 2026
4550.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4550.T stands at 0. In comparison, 4519.T has a market cap of 15.4T. Regarding current trading prices, 4550.T is priced at ¥1,714.00, while 4519.T trades at ¥9,362.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4550.T currently has a P/E ratio of 0.00, whereas 4519.T's P/E ratio is 35.46. In terms of profitability, 4550.T's ROE is +0.65%, compared to 4519.T's ROE of +0.22%. Regarding short-term risk, 4550.T is less volatile compared to 4519.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4550.T.Check 4519.T's competition here